New Key Statistics Module, Z-Score and F-Score
NAS:RNA Key Ratios
| Market Cap $ M | 3,227.32 |
| Enterprise Value $ M | 1,808.59 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.14 |
| Price/Sales | 264.64 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 10.00 |
| EPS (TTM) $ | -2.89 |
| Beneish M-Score | -2.47 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -49.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -5.57 |
| EV-to-EBITDA | -5.62 |
| PEG | -- |
| Shares Outstanding M | 119.31 |
| Net Margin (%) | -2,772.45 |
| Operating Margin % | -3,209.35 |
| Pre-tax Margin (%) | -2,772.45 |
| Quick Ratio | 17.76 |
| Current Ratio | 17.76 |
| ROA % (ttm) | -27.28 |
| ROE % (ttm) | -30.66 |
| ROIC % (ttm) | -590.03 |
| Dividend Yield % | -- |
| Altman Z-Score | 14.69 |
RNA Number of Guru Trades
RNA Volume of Guru Trades
Gurus Latest Trades with NAS:RNA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RNA is held by these investors
Total 1
Avidity Biosciences Inc Insider Transactions
No Available Data
News about NAS:RNA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers